Official websites use .gov
Secure .gov websites use HTTPS
« Previous
Next »
Titles
- Medicare Part D2
- Medicare Part D's medication therapy management: shifting from neutral to drive1
- Medicare Part D: CMS should monitor effects of rebates on drug coverage and spending : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives1
- Medicare Part D: CMS should monitor effects of rebates on plan formularies and beneficiary spending : report to congressional requesters1
- Opioid use in Medicare Part D continued to decline in 2019, but vigilance is needed as COVID-19 raises new concerns1
- Part D plans generally include drugs commonly used by dual eligibles: 20201
- Paying for drugs in Medicare Part D under current law and under proposals to redesign the program1
- The Medicare drug benefit (Part D): the basics1